Indivior Uk competitive analysis

Loading summary...

Explore Indivior Uk's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 1, 2020Buprenorphine Dosing Regimens1
Jan 10, 2018Injectable Flowable Composition Comprising Buprenorphine1

Latest publications and patents of Indivior Uk New

Explore the latest publications and patents granted to Indivior Uk, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Indivior Uk

Jul 1, 2020Buprenorphine Dosing RegimensGranted And Under Opposition
Jan 10, 2018Injectable Flowable Composition Comprising BuprenorphineOpposition Rejected

Latest PTAB cases involving Indivior Uk

Discover the latest PTAB cases involving Indivior Uk, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Indivior Uk

IPR2019-00328Nov 13, 2018DR REDDYS LABORATORIESINDIVIOR UKInstitution Denied
IPR2019-00329Nov 13, 2018DR REDDYS LABORATORIESINDIVIOR UKFinal Written Decision
IPR2016-01113May 31, 2016DR REDDYS LABORATORIESINDIVIOR UKInstitution Denied
IPR2016-00280Dec 3, 2015TEVA PHARMACEUTICALS USAINDIVIOR UKInstitution Denied

Peer Comparison New

IP litigation analysis comparing Indivior Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INDIVIOR UK - 2 - 4
DR REDDYS LABORATORIES9627 -
ELKINGTON AND FIFE91 - - -
TEVA PHARMACEUTICALS20916 - 12